Literature DB >> 19276827

Long-term management of craniofacial osteosarcoma.

Erh-Kang Chou1, Chun-Shin Chang, Philip Kuo-Ting Chen, Yu-Ray Chen, Jack Chung-Kai Yu, Shih-Ming Jung, Sophia Chia-Ning Chang.   

Abstract

Primary osteosarcoma of the calvarium is rare. A 22-year-old female patient was admitted for a progressively enlarging, indurated mass under her scalp for 6 months. A computed tomographic scan revealed a 4 x 3 x 2-cm3 osteolytic lesion over the right parietal cortex with a sunburst appearance. The patient underwent en bloc tumor resection using bicortical parietal craniectomy with a 2-cm margin of normal bone, including the tightly adherent periosteum over the tumor. Immediate cranioplasty was performed with split-thickness autogenous calvarial bone grafts. Histopathologic examination showed the tumor to be a primary high-grade osteosarcoma of the skull. She received postoperative chemotherapy. She has recovered well and remains without any evidence of disease at her most recent, 8-year follow-up. The key to disease-free survival in treating primary osteosarcoma of the calvarium is complete surgical resection with immediate reconstruction followed by adjuvant chemotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19276827     DOI: 10.1097/SCS.0b013e31819b9641

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  Cloud-like pattern of mineralization in skull base osteosarcoma.

Authors:  Lakshmi Narayan Garg; Amit Agrawal; Rekha Goyal; Shyam Sunder Trehan; Amit Mittal; Nikhil Dureja
Journal:  J Neurosci Rural Pract       Date:  2011-01

2.  Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis.

Authors:  Enrico Martin; Joeky T Senders; P Valerie Ter Wengel; Timothy R Smith; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2018-12-21       Impact factor: 2.216

Review 3.  Primary osteosarcoma of frontal bone: A case report and review of literature.

Authors:  Guangyong Wu; Qi Liang; Yu Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.